ABCG2+ cells and the mRNA levels in CML patients in different phases exhibited no substantial differences (P>0.05) but were obviously higher than in normal donors (Fig. 4a–b). The gene discussed is ABCG2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.